Systematic Review and Meta-Analysis on the Association Between Outpatient Statins Use and Infectious Disease-Related Mortality
Lu, JiahaiNote: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationMa, Yu, Xiaozhong Wen, Jing Peng, Yi Lu, Zhongmin Guo, and Jiahai Lu. 2012. Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality. PLoS ONE 7(12): e51548.
AbstractBackground: To update and refine systematic literature review on the association between outpatient statins use and mortality in patients with infectious disease. Materials and Methods: We searched articles published before September 31, 2012, on the association between statins and infectious disease-related mortality through electronic databases. Eligible articles were analyzed in Review Manager 5.1. We conducted stratification analysis by study design, infection types, clinical outcomes and study locations. Results: The pooled odds ratio (OR) for death (statins use vs. no use) across the 41 included studies was 0.71 (95% confidence interval: 0.64, 0.78). The corresponding pooled ORs were 0.58 (0.38, 0.90), 0.66 (0.57, 0.75), 0.71 (0.57, 0.89) and 0.83 (0.67, 1.04) for the case-control study, retrospective cohort studies, prospective cohort studies and RCTs; 0.40 (0.20, 0.78), 0.61 (0.41, 0.90), 0.69 (0.62, 0.78) and 0.86 (0.68, 1.09) for bacteremia, sepsis, pneumonia and other infections; 0.62 (0.534, 0.72), 0.68 (0.53, 0.89), 0.71 (0.61, 0.83) and 0.86 (0.70, 1.07) for 30-day, 90-day, in-hospital and long-term (>1 year) mortality, respectively. Conclusions: Outpatient statins use is associated with a lower risk of death in patients with infectious disease in observational studies, but in a less extent in clinical trials. This association also varies considerably by infection types and clinical outcomes.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:11177913
- HMS Scholarly Articles